📌 Key Takeaways
- Topic: Silica as a Thickening Agent: How It Works in Liquids, Resins and Gels
- Keywords: silicon dioxide formula
- Published: 2026-11-20 14:31:59
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Supplier Japan: Leading Producers and High-Purity Sourcing Options
- Ultrafine Silica Powder: Particle Sizes, Specifications and Applications
- High Purity Quartz Sand: Specifications, Uses in Solar and Semiconductors, and Suppliers
- 15. Hong X., Zhong X., Du G., Hou Y., Zhang Y., Zhang Z., Gong T., Zhang L., Sun X. The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency. Sci. Adv. 2020;6:eaaz4462. doi: 10.1126/sciadv.aaz4462. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
- Silica for Underfill: Submicron Spherical Silica Requirements and Selection
- 61. Tzankov B., Voycheva C., Tosheva A., Stefanova D., Tzankova V., Spassova I., Kovacheva D., Avramova K., Tzankova D., Yoncheva K. Novel oleogels for topical delivery of quercetin based on mesoporous silica MCM-41 and HMS particles. J. Drug Deliv. Sci. Technol. 2023;86:104727. doi: 10.1016/j.jddst.2023.104727. [ DOI ] [ Google Scholar ]
- Monodisperse Silica Spheres: Size Control, Synthesis and Applications
What Is the Density of Silica? Values for Quartz, Fused and Amorphous Silica
What is silica (SiO₂)?
silica aerogel
What is the difference between fumed silica and precipitated silica?
microsilica for cement
What drives silica raw material prices?
silica gel column chromatography Nanoparticles (NPs) would naturally encounter some difficulties in accessing ideal targets. They can be deposited in non-target tissues due to physiological barriers, heterogeneity of receptor expression, and defective targeting mechanisms, and therefore become potentially toxic and less effective [ 80 ]. In addition, environment-sensitive systems responsive to environmental stimuli such as pH may be activated before their intended use, or in normal tissues if the same environmental circumstances are present, leading to unwanted release of the drug [ 81 ]. Biological heterogeneity of patients, i.e., immune factors such as anti-PEG antibodies, may influence the biodistribution of nanoparticles and off-target interactions as well [ 80 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.